Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Average Recommendation of “Moderate Buy” from Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) has been given an average recommendation of “Moderate Buy” by the seven research firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a strong buy rating to the company.

Several brokerages recently issued reports on RBGLY. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. JPMorgan Chase & Co. cut Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a report on Thursday, August 29th. Barclays raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. Finally, Sanford C. Bernstein cut shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th.

Reckitt Benckiser Group Stock Performance

Reckitt Benckiser Group stock opened at $12.04 on Tuesday. The company has a fifty day simple moving average of $12.31 and a 200-day simple moving average of $11.63. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a 52-week low of $10.24 and a 52-week high of $15.03.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.